Company Records 250,000 Patient Visits in First Six Months Since AMD Purchase, Then Triples to 750,000 in the Following Six Months
VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), an innovator in the eHealth sector, is pleased to announce that UniDoc Connect, the Company's enterprise eHealth platform, has surpassed one million recorded patient visits.
Key Takeaways:
UniDoc Connect has surpassed one million recorded patient visits since UniDoc's March 2025 acquisition of AGNES Connect software and related AMD Telemedicine assets.
UniDoc Connect recorded 260,000 visits from March through September 2025 and passed one million by April 2026.
The increase reflects new customers and expanded use by customers that transitioned to UniDoc through the AMD purchase.
UniDoc Connect
UniDoc Connect is the Company's enterprise eHealth software platform for remote clinical workflows. It supports medical device data, documents, medical images and live video within a web-based platform and is used by healthcare organizations across care settings. UniDoc Connect can be used both as a standalone eHealth platform and as part of an integrated hardware and software eHealth solution in products like the H3 Health Cube.
From 260,000 Visits to One Million
The one million patient visit threshold gives the Company a usage benchmark for UniDoc Connect. The count begins with visits recorded after UniDoc's March 2025 acquisition of AGNES Connect software and related AMD Telemedicine assets.
From March through September 2025, UniDoc Connect recorded 260,000 patient visits. By April 2026, recorded visits had passed one million. More than 740,000 recorded visits were added after September 2025 as the Company continued to integrate customers and support active use cases. Patient visits refer to recorded platform visits and should not be interpreted as unique patients.
The usage increase follows the Company's completed integration of AMD Telemedicine software and related systems into UniDoc's operating structure. Since the purchase, UniDoc has aligned product naming, support, sales and product development under UniDoc Connect.
Customer Utilization
Management believes the increase reflects two active parts of the commercial plan: adding new UniDoc Connect customers and working with customers that came to UniDoc through the AMD purchase to better utilize systems already in place. That work includes account support, workflow review and user re-engagement.
The Company believes the patient visit milestone provides a reference point for discussions with clinics, health systems, governments and channel partners as UniDoc continues commercialization.
Management Comment
"Reaching one million recorded patient visits is a clear marker for UniDoc," said Tony Baldassarre, CEO of UniDoc Health Corp. "Increasing from around a quarter of a million visits in the first half of the year to over one million visits in the second half, shows a substantial growth in patient visits. We believe this growth has come from two places - the first being from new customers and the second from our efforts in working with existing customers [that came to UniDoc through the AMD purchase] to help them better utilize their systems. That is the operating plan: bring customers onto the platform, support them and turn installed systems into active clinical workflows."
On Behalf of the Board of Directors,
~ Tony Baldassarre ~
Antonio (Tony) Baldassarre
CEO, President & Director
UniDoc Health Corp.
About UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)
UniDoc is developing eHealth solutions intended to support virtual clinical consultations through remote healthcare points of service. The Company combines software, diagnostic devices and communications tools so patients can access consultations from locations outside a physician's office. UniDoc's focus is physical access: helping governments, institutions and organizations deploy remote clinical access points for populations challenged by distance, access, technology use or care availability.
UniDoc is focused on building shareholder value through product deployment, commercialization and partnerships. More information is available at www.unidoctor.com.
For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com
Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com
Media Inquiries: media@unidoctor.com
